These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27683411)

  • 1. Potential Markers in Cardiac Hypertrophy?
    Malinowski B; Fulgheri G; Wicinski M; Grzesk E; Odrowaz-Sypniewska G; Grześk G; Darwish N
    EJIFCC; 2012 Jul; 23(2):41-6. PubMed ID: 27683411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure.
    Oh KS; Lee JH; Yi KY; Lim CJ; Park BK; Seo HW; Lee BH
    Eur J Pharmacol; 2017 Mar; 799():94-102. PubMed ID: 28163023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differentiation of the competitive athlete with physiologic cardiac remodeling from the athlete with cardiomyopathy.
    Henning RJ
    Curr Probl Cardiol; 2024 Sep; 49(9):102473. PubMed ID: 38447749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension.
    Ndisang JF; Chibbar R; Lane N
    Eur J Pharmacol; 2014 Jul; 734():23-34. PubMed ID: 24726875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of osteopontin hormone with TIMI score and cardiac markers in patients with acute coronary syndrome presenting with chest pain.
    Akan AŞ; Özlü I
    Cardiovasc J Afr; 2024 Feb; 34():1-8. PubMed ID: 38407428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chest pain syndrome in normal or non-diagnostic conventional ECG at the emergency service. Assessment with myocardial perfusion (SPECT) and ventricular function (Gated-SPECT)].
    Bialostozky D
    Arch Cardiol Mex; 2004; 74 Suppl 1():S18-31. PubMed ID: 15216744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases.
    Onan D; Pipolo L; Yang E; Hannan RD; Thomas WG
    Mol Endocrinol; 2004 Sep; 18(9):2344-54. PubMed ID: 15205471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterculia tragacantha Lindl Aqueous Leaf Extract Ameliorate Cardiomyopathy in Streptozotocin-induced Diabetic Rats via Urotensin II and FABP3 Expressions.
    Ajiboye BO; Oyinloye BE; Onikanni SA; Osukoya OA; Lawal OE; Bamisaye FA
    J Oleo Sci; 2021; 70(12):1805-1814. PubMed ID: 34866110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of hypertrophic cardiomyopathies by non-ECG-gated cardiac computed tomography (CCT).
    Kuhn H; Blümm R; Gietzen F; Böcker K; Wassmuth E
    Z Kardiol; 1987; 76 Suppl 3():53-6. PubMed ID: 3433875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy diagnosed after a stroke: a case report.
    Umeojiako WI; Kanyal R
    J Med Case Rep; 2018 Mar; 12(1):76. PubMed ID: 29562910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice.
    Tsuruda T; Sekita-Hatakeyama Y; Hao Y; Sakamoto S; Kurogi S; Nakamura M; Udagawa N; Funamoto T; Sekimoto T; Hatakeyama K; Chosa E; Kato J; Asada Y; Kitamura K
    Hypertension; 2016 May; 67(5):848-56. PubMed ID: 27001297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.
    Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future circulating biomarkers for cardiac amyloidosis.
    Luciani M; Troncone L; Monte FD
    Acta Pharmacol Sin; 2018 Jul; 39(7):1133-1141. PubMed ID: 29770800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Yield of Genetic Testing in Young Athletes With T-Wave Inversion.
    Sheikh N; Papadakis M; Wilson M; Malhotra A; Adamuz C; Homfray T; Monserrat L; Behr ER; Sharma S
    Circulation; 2018 Sep; 138(12):1184-1194. PubMed ID: 29764897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Noncompaction Cardiomyopathy in an Elderly Patient: A Case Report and Literature Review.
    Okan T; Lodeen H; Abawkaw M; Stetsiv T; Semeniv V
    Cureus; 2023 Apr; 15(4):e38305. PubMed ID: 37261174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current applications of biomarkers in cardiomyopathies.
    Coats CJ; Heywood WE; Mills K; Elliott PM
    Expert Rev Cardiovasc Ther; 2015; 13(7):825-37. PubMed ID: 26106935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing sensitivity and specificity of the Manchester Triage System in the evaluation of acute coronary syndrome in adult patients in emergency care: a systematic review protocol.
    Nishi FA; de Motta Maia FO; de Lopes Monteiro da Cruz DA
    JBI Database System Rev Implement Rep; 2015 Nov; 13(11):64-73. PubMed ID: 26657465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid Cardiomyopathy in the Emergency Department.
    Baca M; Newberry M
    J Emerg Med; 2019 Feb; 56(2):205-209. PubMed ID: 30553561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy in infants: clinical features and natural history.
    Maron BJ; Tajik AJ; Ruttenberg HD; Graham TP; Atwood GF; Victorica BE; Lie JT; Roberts WC
    Circulation; 1982 Jan; 65(1):7-17. PubMed ID: 6458422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Feline Cardiomyopathies: 1. General concepts.
    Kittleson MD; Côté E
    J Feline Med Surg; 2021 Nov; 23(11):1009-1027. PubMed ID: 34693806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.